Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.

Get ready for medicine making level 2 as video games come to healthcare backed with clinical trial data that demonstrate efficacy.

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

Our eBook features drug development stories, a drive for novel excipients, new technologies, and more.

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.

Enveda Biosciences Founder Viswa Colluru shares the lessons he has learned whilst charting the vast terra incognita of nature’s chemical structure

Yvonne Duckworth lays out insights into Pharma 4.0 gleaned in a recent report by CRB. VR, AR, AI: is it more than just alphabet soup?

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

IFPMA’s Director-General, Thomas Cueni, outlines how companies worldwide can foster long-term tech transfer partnerships.